Charles Breeling, MD
Family Medicine · Corpus Christi, TXNPI 1346358413
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.2% of the total across 474 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 37 manufacturers, the largest accounting for just 18.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $1,831 and has fallen 72.0% since, to $513 in 2025. Among family medicine clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 474 payments — averaging $14.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- Lilly USA, LLC$997
- AbbVie$907
- Pfizer$518
- Merck$338
- GSK$245
- plus $2K from 31 others
What the payments were for
- Food & beverage$6,58899%
- Education$561%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 116 | $1,227 |
| Lilly USA, LLC | 89 | $997 |
| AbbVie(2 entities) | 59 | $907 |
| Pfizer | 31 | $518 |
| Merck | 26 | $338 |
| GSK | 16 | $245 |
| Amgen(2 entities) | 17 | $234 |
| Bayer | 7 | $223 |
| Sanofi-aventis U.S. LLC | 17 | $216 |
| Boehringer Ingelheim | 10 | $169 |
| Johnson & Johnson | 10 | $155 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $125 |
| Astellas Pharma US Inc | 7 | $117 |
| Amarin Pharma, Inc. | 7 | $113 |
| Sumitomo Pharma America, Inc. | 5 | $98 |
| Phathom Pharmaceuticals, Inc. | 4 | $88 |
| Novartis | 4 | $86 |
| Abiomed | 2 | $83 |
| AstraZeneca | 5 | $77 |
| Exact Sciences | 4 | $64 |
| Dexcom, Inc. | 3 | $63 |
| Kowa Pharmaceuticals America, Inc. | 3 | $56 |
| Otsuka America Pharmaceutical, Inc. | 3 | $55 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $51 |
| Axsome Therapeutics, Inc. | 2 | $47 |
| Inspire Medical Systems, Inc. | 2 | $44 |
| Neuronetics, Inc. | 1 | $36 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $33 |
| Esperion Therapeutics, Inc. | 2 | $30 |
| Shield Therapeutics Inc | 2 | $30 |
| Teva Pharmaceuticals USA, Inc. | 2 | $25 |
| Halozyme Inc | 1 | $25 |
| Abbott | 1 | $19 |
| VBI Vaccine (delaware) Inc. | 1 | $15 |
| Boston Scientific | 1 | $14 |
| Tris Pharma Inc | 1 | $13 |
| Shire North American Group Inc | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerendia$122
How this compares
$6,644 in reported general payments places this provider in the 90th percentile of 8,760 family medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 136 | $159,397 |
| MounjaroTirzepatide | 107 | $144,608 |
| Avonex Pen (4 Pack)Interferon Beta-1a | 14 | $134,281 |
| JardianceEmpagliflozin | 110 | $102,405 |
| JanuviaSitagliptin Phosphate | 102 | $100,007 |
| EliquisApixaban | 107 | $90,682 |
| FarxigaDapagliflozin Propanediol | 91 | $89,623 |
| TrintellixVortioxetine Hydrobromide | 26 | $32,874 |
| RybelsusSemaglutide | 22 | $28,533 |
| TrulicityDulaglutide | 18 | $25,854 |
| Teriparatide | 12 | $25,510 |
| MyrbetriqMirabegron | 33 | $23,618 |
| XareltoRivaroxaban | 26 | $21,712 |
| EntrestoSacubitril/Valsartan | 14 | $19,222 |
| JanumetSitagliptin Phos/Metformin Hcl | 15 | $16,568 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $1,227 | $187,930158 claims |
| Lilly USA, LLCMounjaro, Trulicity | $997 | $170,461125 claims |
| MerckJanuvia, Janumet | $338 | $116,575117 claims |
| Boehringer IngelheimJardiance, Tradjenta | $169 | $113,456126 claims |
| AstraZenecaFarxiga, Brilinta, Symbicort | $77 | $100,871115 claims |
| PfizerEliquis, Premarin | $518 | $98,057124 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $125 | $32,87426 claims |
| Astellas Pharma US IncMyrbetriq | $117 | $23,61833 claims |
| Johnson & JohnsonXarelto | $155 | $21,71226 claims |
| NovartisEntresto | $86 | $19,22214 claims |
| Kowa Pharmaceuticals America, Inc.Livalo | $56 | $9,63017 claims |
| AbbVieSynthroid | $907 | $4,45577 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 8,760 family medicine providers in Texas.
Other family medicine in Corpus Christi
- Carlos CamposNew Braunfels$1.5M
- Aaron KingSan Antonio$1.1M
- Bradley WassonArlington$734K
- Cynthia BrinsonAustin$402K
- Michael MendezLubbock$368K
- Sang Tae KimAmarillo$368K
- Sumit PerakathuHarlingen$342K
- Joel SolisMcAllen$324K
- Robert CampbellFort Worth$318K
- Jose LedezmaEdinburg$300K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.